Washington, District of Columbia
United States
28
2024-07-11
The entities that hold a legal rights for patent applications filed by inventor Sadoff Jerald C.:
Jerald C. Sadoff from Washington, US has applied for patents for these inventions. The list has both pending applications and granted patents:
CALIBRATION OF ELISA FOR CLINICAL ANTIBODY RESPONSE BY QUANTITATIVE MASS SPECTROMETRY
#2 | 2024-04-25CALIBRATION OF ELISA FOR CLINICAL ANTIBODY RESPONSE BY QUANTITATIVE MASS SPECTROMETRY
#3 | 2023-03-09Compositions and Methods for Preventing and Treating Coronavirus Infection - Sars-Cov-2 Vaccines
#4 | 2022-09-01CO-ADMINISTRATION OF SEASONAL INFLUENZA VACCINE AND AN ADENOVIRUS BASED RESPIRATORY SYNCYTIAL VIRUS VACCINE
#5 | 2022-06-23PROPHYLACTIC TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION WITH AN ADENOVIRUS BASED VACCINE
#6 | 2021-12-16Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
#7 | 2021-08-12Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
#8 | 2013-08-29Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
#9 | 2011-08-25Malaria vaccine compositions and constituents which elicit cell mediated immunity
#10 | 2011-05-19Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease
#11 | 2011-05-19ENHANCEMENT OF TRANSGENE EXPRESSION FROM VIRAL-BASED VACCINE VECTORS BY EXPRESSION OF SUPPRESSORS OF THE TYPE I INTERFERON RESPONSE
#12 | 2011-04-14Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
#13 | 2010-09-16Recombinant BCG strains with enhanced ability to escape the endosome
#14 | 2010-02-25Recombinant BCG strains with enhanced ability to escape the endosome
#15 | 2010-01-07Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
#16 | 2009-12-10NOVEL PRIME-BOOST COMBINATIONS OF ATTENUATED MYCOBACTERIUM
#17 | 2009-05-28Recombinant BCG tuberculosis vaccine designed to elicit immune responses to in all physiological stages of infection and disease
#18 | 2009-05-14Generation of new BCG vaccine strains protecting against the establishment of latent infection and reactivation from the latent or persistent state
#19 | 2009-03-12Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
#20 | 2008-11-20Electroporation of and overexpression of antigens in mycobacteria
#21 | 2008-05-08Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof
#22 | 2008-04-24Recombinant BCG strains with enhanced ability to escape the endosome
#23 | 2007-06-26Bacterial delivery system
#24 | 2006-06-08Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria
#25 | 2006-06-01Recombinant BCG strains with attenuated immunosuppressive properties
#26 | 2006-06-01Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof
#27 | 2006-05-16Bacterial delivery system
#28 | 2005-03-29Conjugate vaccine against gram-negative bacterial infections
413829 ⎘